Bruton's tyrosine kinase inhibitors: a new class of multiple sclerosis therapeutics. Oh J, Bar-Or A, Montalban X, Sormani M P, Weber MS, Reich DS Lancet Neurol. 2026 Jul; 25(7):673-688. PMID: 42309088. Abstract CommentRecommendBookmarkWatch
